This retrospective analysis investigates the occurrence of acute kidney injury in pts with type 2 diabetes who receive vancomycin via home infusion. The study aims to shed a light on the prevalence, risk factors and mgmt. strategies related to AKI in this specific pt population.
A home infusion provider transitioning to innovative technologies paving the way to integrating artificial intelligence to increase patient engagement, improve quality outcomes, and reduce cost.
This session will provide a solid foundation for an organization to develop and implement an effective hazard communication program.
Discussing how to better care for the long-term pediatric IV patient at home. Our goal is to bring kids home sooner and keep kids home longer, because every kid deserves to be a kid!
This retrospective analysis investigates the occurrence of acute kidney injury in patients with type 2 diabetes mellitus who receive Vancomycin via home infusion. The study aims to shed light on the prevalence, risk factors, and management strategies related to AKI in this specific pt population.
#PowerOfTwo: Learn how coordinated HPEN & enteral care can revolutionize patient outcomes. This session explores strategies to optimize therapy, improve quality of life, and streamline care delivery. #nutrition #healthcare #enteralfeeding
Drug shortages have become part of everyday practice, but navigating through them requires an interdisciplinary approach.
To Build or Not to Build: And Other Questions About Expansion = #pharmacybusinessgrowth Leveraging Collaborative Practice Agreements as One Health System = #pharmacistproviderstatus
Defining work place hazardous is an employee right, having an effective hazardous drug list is the starting point for pharmacies.
Empower TPN consumers to self-triage at home! Join our interactive session to learn how to distinguish routine, urgent, & emergent complications in catheter & electrolyte care. #HomeInfusion #PatientEducation
Tuesday morning at NHIA 2025 featured a breakfast symposium covering the clinical management of adverse reactions in immunoglobulin therapy, and our innovative 30-30-30 sessions that cover a central topic from 3 angles with unique perspectives. For example, IV workflow systems were examined from history of their development and use in hospital systems, to their current adoption in home infusion practice, and how to implement such a system if your organization chooses to operationalize one.
Monday morning kicked off with a high-octane networking breakfast before the General Session. We were fortunate to hear from Dr. Mark McClellan, who was FDA Commissioner and CMS Administrator under the George W. Bush administration, who joined NHIA President and CEO Connie Sullivan for a fireside chat.
NHIA 2025 convened the largest gathering dedicated to the home and alternate site infusion industry in Washington, D.C., featuring the event’s most extensive Expo ever with 150 product and service suppliers supporting the industry, including 39 first-time exhibitors. The conference continued to see an increase in individuals investing to attend the conference and nearly 1,600 industry professionals attended the 5-day event.
This retrospective analysis investigates the occurrence of acute kidney injury in pts with type 2 diabetes who receive vancomycin via home infusion. The study aims to shed a light on the prevalence, risk factors and mgmt. strategies related to AKI in this specific pt population.
